Coskun 2025 - Retatrutide Effects on Body Composition in Type 2 Diabetes

The Lancet Diabetes & Endocrinology·January 1, 2025

T. Coskun

Summary

Retatrutide significantly improved total body fat mass reduction compared with placebo and dulaglutide in adults with type 2 diabetes.

Study Details

Study Design

Body-composition analysis from clinical trial data

Indication

Type 2 diabetes and obesity-related body composition

Intervention

Retatrutide vs placebo and dulaglutide comparator

Species

Human

Risk of Bias Assessment

Secondary/body-composition analysis; sponsor-associated